SPT7 Antibody

What are the different forms of SPT7 detected in yeast cells?

Research has identified three distinct forms of SPT7 in yeast:

• Full-length SPT7 (Spt7 SAGA) - Approximately 220 kDa, found in the SAGA complex

• Truncated SPT7 (Spt7 SLIK) - Approximately 200 kDa, present in the SLIK/SAGA alt/SALSA complex

• SPT7 Form3 - Approximately 160 kDa (about 20 kDa smaller than Spt7 SLIK)

These different forms are detected through Western blotting using epitope-tagged versions of SPT7 (TAP, Flag, or myc tags). In wild-type strains, the ratio of SAGA:SLIK forms is approximately 3:1 .

What is the relationship between SAGA and SLIK/SAGA alt/SALSA complexes?

Both complexes function as histone acetyltransferase/transcriptional coactivators, but contain distinct forms of SPT7. The key differences include:

The difference in SPT7 processing appears to occur during biosynthesis of distinct complexes rather than as part of normal SAGA functioning . Research suggests SLIK may play a subtle role in transcription that's partially redundant with SAGA functions .

How can I investigate the mechanism of SPT7 processing in different genetic backgrounds?

To investigate SPT7 processing mechanisms effectively:

• Introduce epitope-tagged SPT7 (e.g., YCpDed-TAP-Flag-SPT7) into wild-type and deletion strain backgrounds

• Analyze protein extracts via Western blotting with appropriate antibodies (anti-Flag, anti-TAP)

• Compare the relative abundance of different SPT7 forms across genetic backgrounds

The experimental approach should include appropriate controls:

• Empty vector controls to identify cross-reactive bands

• Verification in both wild-type and spt7Δ0 strain backgrounds

• Comparison of multiple epitope tags to rule out tag-specific artifacts

What regions of SPT7 are critical for its different functions and processing?

Through mutation analysis and domain mapping, researchers have identified key functional regions:

• A specific region of SPT7 required for interaction with the SAGA component Spt8

• An adjacent domain required for processing to generate the SLIK form

To investigate these domains:

• Create a series of SPT7 deletion constructs (e.g., SPT7 580-1332, SPT7 872-1332, SPT7 1038-1332)

• Express these constructs in spt7Δ0 strains to avoid interference from endogenous SPT7

• Analyze processing patterns and interactions with SAGA components

• Correlate molecular phenotypes with functional outcomes in transcription assays

This approach has revealed that the interaction of Spt8 with the C-terminal end of SPT7 is specifically lost in the processed SLIK form .

How does SPT7 processing affect its incorporation into protein complexes?

To investigate how different SPT7 forms associate with protein complexes:

• Generate strains expressing epitope-tagged SPT7 (N-terminal tagging preserves C-terminal processing)

• Apply crude protein extracts to gel filtration chromatography (e.g., Superose 6 HR10/30 column)

• Analyze elution fractions by Western blotting with anti-epitope antibodies

• Determine the relative amounts of different SPT7 forms by densitometry

Research shows all three SPT7 forms elute in high molecular mass fractions, with Spt7 SAGA being largest, followed by Spt7 SLIK, and Spt7 Form3 slightly smaller than SLIK . To determine specific complex associations, complement this approach by purifying complexes containing TAP-tagged SAGA components (Gcn5, Ada2, Ubp8, Taf5, Spt3, Spt8) and analyzing the presence of different SPT7 forms by Western blotting .

What are the optimal antibody-based strategies for detecting SPT7 forms?

For reliable detection of different SPT7 forms, researchers should consider:

• Epitope tagging approach:

  • N-terminal tagging with Flag, TAP, or myc epitopes has been successfully demonstrated

  • Example constructs: YCpDed-TAP-Flag-SPT7, YCp88-myc-SPT7

  • N-terminal tagging preserves C-terminal processing events

• Antibody selection:

  • Anti-Flag antibody detects both full-length and processed forms but may show cross-reactivity

  • Anti-myc antibody provides effective detection with potentially less background

  • For tandem affinity purification, IgG-agarose followed by calmodulin-sepharose works effectively

• Protein separation:

  • Use 6-8% SDS-PAGE gels to effectively resolve high molecular weight forms (160-220 kDa)

  • Consider additional purification steps if cross-reactive bands obscure specific forms

How can I construct SPT7 expression systems for functional studies?

To establish effective SPT7 expression systems:

• Plasmid selection:

  • LEU2-containing centromeric plasmid YCplac111 for stable, low-copy expression

  • URA3-containing YCp88 for alternative selection marker needs

• Promoter options:

  • DED1 promoter for constitutive expression

  • GAL10 promoter for inducible expression

• Epitope tag incorporation:

  • Insert epitope tag coding sequences at engineered NotI sites

  • For Flag epitope, use annealed oligonucleotides encoding Met-Tyr-Lys-Asp-4-Lys sequence

• Integration strategy:

  • For studies requiring genomic integration, use YIplac211-based constructs

  • Target integration to the endogenous locus using appropriate restriction sites (e.g., SalI)

This approach allows for flexible experimental design, enabling both plasmid-based and integrated expression systems for studying SPT7 function under different conditions.

What purification protocols yield intact SPT7-containing complexes?

For isolating intact SPT7-containing complexes:

• Single-step purification:

  • Immunoprecipitation with anti-Flag antibody directly from crude extracts

  • IgG-agarose purification of TAP-tagged constructs

• Tandem affinity purification:

  • Sequential purification through IgG-agarose and calmodulin-sepharose for highest purity

  • Successfully demonstrated for isolating SPT7 complexes from both wild-type and spt7Δ0 backgrounds

• Size fractionation:

  • Apply crude extracts or partially purified samples to Superose 6 HR10/30 gel filtration column

  • Collect fractions and analyze by Western blotting to separate different SPT7-containing complexes

For all approaches, maintain appropriate buffer conditions to preserve complex integrity throughout the purification process.

How should I interpret changes in SPT7 processing patterns?

When analyzing SPT7 processing patterns across experiments:

• Baseline establishment:

  • In wild-type strains, expect a SAGA:SLIK ratio of approximately 3:1

  • Look for the appearance of all three forms (220 kDa, 200 kDa, and 160 kDa)

• Altered ratios interpretation:

  • Increased SLIK:SAGA ratio may indicate enhanced processing

  • Decreased SLIK:SAGA ratio (as seen in ubp8Δ0 strains) suggests impaired processing

  • Some strain backgrounds (e.g., spt20Δ0) may show altered ratios potentially due to differential stability of forms

• Novel bands analysis:

  • Confirm specificity through comparison with control samples (empty vector, untagged strains)

  • Consider whether novel bands represent additional processing events or degradation products

• Complex association changes:

  • Full-length SPT7 exclusively interacts with Spt8

  • Both Spt7 SAGA and Spt7 SLIK interact with other SAGA components (Gcn5, Ada2, Ubp8, Taf5, Spt3)

  • Spt7 Form3 shows reduced co-purification with SAGA components

What are common pitfalls in SPT7 antibody-based experiments?

Researchers should be aware of several technical challenges:

• Antibody cross-reactivity:

  • Flag antibodies can produce cross-reactive bands that obscure SPT7 Form3

  • Additional purification steps may be necessary for clear visualization

• Size discrimination challenges:

  • The three SPT7 forms (220, 200, and 160 kDa) require well-optimized gel conditions for clear separation

  • High-percentage gels may compress bands in this size range

• Processing kinetics:

  • C-terminal processing occurs rapidly after synthesis

  • Time-course experiments need appropriate early time points to capture processing events

• Expression level effects:

  • Overexpression may alter normal processing patterns

  • Consider using endogenous promoters or carefully titrated inducible systems for physiologically relevant results

• Strain background influences:

  • Some deletion strains may affect the stability of specific SPT7 forms

  • Compare results across multiple backgrounds when possible

How does SAGA complex disassembly affect SPT7 detection?

When investigating SAGA complex disassembly:

• Research demonstrates that SPT7 processing to Spt7 SLIK and Spt7 Form3 occurs in the absence of Ada1 and Spt20, which are required for SAGA complex integrity .

• This suggests SPT7 processing represents a biosynthesis pathway for distinct Spt7-containing complexes rather than signaling events during SAGA function .

• When designing experiments to study SPT7 in disassembled complexes:

  • Use deletion strains lacking core SAGA components (ada1Δ0, spt20Δ0)

  • Confirm complex disassembly through co-immunoprecipitation studies

  • Examine SPT7 processing patterns through Western blotting

  • Consider that partial SAGA complexes containing SPT7 can still form in these backgrounds

• SPT7 appears to maintain some function even in partially assembled complexes, suggesting it may have roles independent of the complete SAGA complex that merit further investigation .

What emerging technologies are advancing SPT7 antibody applications?

Current research is exploring several technological advances:

• Structure-function analysis:

  • Targeted mutagenesis to identify specific residues required for processing

  • Domain-swapping experiments to determine processing sequence specificity

• Quantitative proteomics:

  • SILAC (Stable Isotope Labeling with Amino acids in Cell culture) approaches to quantify processing kinetics

  • Cross-linking mass spectrometry to map interaction surfaces in different SPT7-containing complexes

• Live-cell imaging:

  • Fluorescently-tagged SPT7 to monitor dynamic processing in living cells

  • FRAP (Fluorescence Recovery After Photobleaching) to assess complex stability and turnover

These approaches will extend current biochemical and genetic analyses to provide deeper insights into SPT7 function in transcriptional regulation.

How does understanding SPT7 processing contribute to broader transcription research?

SPT7 processing research has broader implications for understanding:

• Complex assembly pathways:

  • The biosynthesis model for SPT7 processing suggests distinct assembly pathways for related transcriptional complexes

  • This may represent a common mechanism for generating functional diversity from shared components

• Regulatory mechanisms:

  • The existence of multiple SPT7-containing complexes suggests refined transcriptional control strategies

  • Differential processing may enable context-specific gene regulation

• Evolutionary conservation:

  • Investigating whether similar processing mechanisms exist in higher eukaryotes

  • Potential insights into the evolution of transcriptional regulatory complexity

Understanding SPT7 processing provides a model system for investigating how post-translational modifications and processing events contribute to transcriptional complex diversity and function.